Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Wiley full text link Wiley Free PMC article
Full text links

Actions

Share

Case Reports
.2020 Aug 9;8(12):2568-2573.
doi: 10.1002/ccr3.3218. eCollection 2020 Dec.

Trimethoprim-induced drug reaction with eosinophilia and systemic symptoms (DRESS) associated with reactivation of human herpes virus-6 (HHV-6) leading to acute liver failure

Affiliations
Case Reports

Trimethoprim-induced drug reaction with eosinophilia and systemic symptoms (DRESS) associated with reactivation of human herpes virus-6 (HHV-6) leading to acute liver failure

Mohsan Subhani et al. Clin Case Rep..

Abstract

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome can have insidious symptoms which may lead to acute liver failure and death. Prompt recognition, stopping offending drug, and initiating corticosteroid are the mainstay of treatment. Early involvement of a specialist liver unit is vital.

Keywords: acute liver failure; drug reaction with eosinophilia and systemic symptoms; drug‐induced liver injury; human herpes virus‐6; jaundice; liver transplant.

© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

FIGURE 1
FIGURE 1
CT Abdomen: Lymphadenopathy with marked hepatosplenomegaly
FIGURE 2
FIGURE 2
Liver histology: Subacute liver failure secondary to submassive hepatocellular necrosis. Representative macroscopic and microscopic images: A, Representative macroscopic section of the explanted liver. The liver is collapsed (723 g) with a single small area of residual parenchyma (inset), cholestatic (marked with arrows). B, Low magnification microscopy of this area demonstrates centrilobular‐based hepatocellular loss with bridging hepatocyte loss and collapse (*), in contrast with the total absence of hepatocytes observed in most of the liver tissue. Hepatocyte specific antigen immunostaining highlights the map‐like appearance of the area, 20×. C, Higher magnification of a centrilobular area, with perivenular confluent hepatocyte loss (*). Portal tracts (PT) show overall mild inflammation, with predominantly lymphocytes and occasional plasma cells and eosinophils. Residual hepatocytes show acute bilirubinostasis (arrows), H&E, 200×. D, Sirius red stain shows, no evidence of significant fibrosis, only collapse 200×
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Walsh SA, Creamer D. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. Clin Exp Dermatol. 2011;36(1):6‐11. - PubMed
    1. Kardaun SH, Sekula P, Valeyrie‐Allanore L, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169(5):1071‐1080. - PubMed
    1. Lin IC, Yang HC, Strong C, et al. Liver injury in patients with DRESS: a clinical study of 72 cases. J Am Acad Dermatol. 2015;72(6):984‐991. - PubMed
    1. Walsh S, Diaz‐Cano S, Higgins E, et al. Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases. Br J Dermatol. 2013;168(2):391‐401. - PubMed
    1. Shiohara T, Mizukawa Y. Drug‐induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019. Allergol Int. 2019;68(3):301‐308. - PubMed

Publication types

Related information

LinkOut - more resources

Full text links
Wiley full text link Wiley Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp